SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 134 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,464 | -57.1% | 39,119 | -7.1% | 0.00% | -50.0% |
| Q2 2023 | $54,744 | -31.6% | 42,111 | +158.5% | 0.00% | -60.0% |
| Q3 2022 | $80,000 | -72.8% | 16,290 | -67.8% | 0.01% | -58.3% |
| Q1 2022 | $294,000 | +39.3% | 50,600 | +80.1% | 0.01% | +33.3% |
| Q4 2021 | $211,000 | -26.5% | 28,100 | -11.9% | 0.01% | -43.8% |
| Q3 2021 | $287,000 | -54.3% | 31,908 | -39.1% | 0.02% | -60.0% |
| Q2 2021 | $628,000 | +115.1% | 52,424 | +125.2% | 0.04% | +185.7% |
| Q1 2021 | $292,000 | -66.7% | 23,280 | -74.9% | 0.01% | -65.9% |
| Q3 2020 | $877,000 | +23.2% | 92,845 | +16.9% | 0.04% | +13.9% |
| Q2 2020 | $712,000 | – | 79,424 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,000,000 | $66,540,000 | 6.69% |
| FIC CAPITAL INC | 787,529 | $8,734,000 | 3.47% |
| RA Capital Management | 1,220,209 | $13,532,000 | 1.36% |
| PRINCETON CAPITAL MANAGEMENT INC | 114,120 | $1,266,000 | 0.67% |
| Perceptive Advisors | 800,000 | $8,872,000 | 0.53% |
| Cormorant Asset Management, LP | 361,000 | $4,003,000 | 0.53% |
| Highlander Capital Management, LLC | 43,500 | $482,000 | 0.43% |
| APEX CAPITAL, LLC | 439,900 | $4,878,000 | 0.42% |
| WASATCH ADVISORS LP | 3,091,386 | $34,283,000 | 0.37% |
| Baker Brothers Advisors | 3,230,932 | $35,831,000 | 0.31% |